177 related articles for article (PubMed ID: 11990485)
1. An overview of thromboprophylaxis in malignancy.
Kakkar AK
Haemostasis; 2001; 31 Suppl 1():67. PubMed ID: 11990485
[No Abstract] [Full Text] [Related]
2. [Prolonged out-of-hospital prophylaxis of venous thromboembolism].
Castells X; Vallano A
Med Clin (Barc); 2002 Jun; 119(2):73-4. PubMed ID: 12084374
[No Abstract] [Full Text] [Related]
3. Thrombosis and cancer.
Kakkar AK
Hematol J; 2004; 5 Suppl 3():S20-3. PubMed ID: 15190272
[TBL] [Abstract][Full Text] [Related]
4. [Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty].
Di Minno G; Tufano A
Tumori; 2006; 92(6):suppl 1-15. PubMed ID: 17260505
[No Abstract] [Full Text] [Related]
5. [Heparin and cancer].
Lykke J
Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
[TBL] [Abstract][Full Text] [Related]
6. [The risk of venous thromboembolism during air travel].
Sanchez O
Rev Prat; 2007 Apr; 57(7):721-3. PubMed ID: 17654820
[No Abstract] [Full Text] [Related]
7. The risk of venous thromboembolism in non-large-joint surgeries.
Muntz JE
Orthopedics; 2003 Feb; 26(2 Suppl):s237-42. PubMed ID: 12597232
[TBL] [Abstract][Full Text] [Related]
8. [Chronicity of hypercoagulative state: a favourable evidence for postoperative prolongation of antithrombotic prophylaxis].
Iturbe Hernández T; Cornudella Lacasa R; Moreno Chulilla JA; Gutiérrez Martín M
Med Clin (Barc); 2003 Apr; 120(14):559. PubMed ID: 12724070
[No Abstract] [Full Text] [Related]
9. Are patients with cancer receiving adequate treatment for thrombosis? Results from FRONTLINE.
Wong JE
Cancer Treat Rev; 2003 Jun; 29 Suppl 2():11-3. PubMed ID: 12887944
[TBL] [Abstract][Full Text] [Related]
10. Management of thromboembolic disease in cancer patients.
Levine MN
Haemostasis; 2001; 31 Suppl 1():68-9. PubMed ID: 11990486
[No Abstract] [Full Text] [Related]
11. Thromboprophylaxis in patients undergoing total hip replacement.
Brenkel IJ; Cook RE
Hosp Med; 2003 May; 64(5):281-7. PubMed ID: 12789737
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism and cancer: prevention and therapy.
Lee AY
Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of VTE in women with cancer.
Lee A
Thromb Res; 2005 Feb; 115 Suppl 1():50-4. PubMed ID: 15790155
[No Abstract] [Full Text] [Related]
14. Cancer and venous thromboembolism. Clinical implications of strong association.
Prandoni P
Pathophysiol Haemost Thromb; 2006; 35(1-2):111-5. PubMed ID: 16855355
[TBL] [Abstract][Full Text] [Related]
15. Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents.
Iorio A
J Thromb Haemost; 2004 Jul; 2(7):1055-7. PubMed ID: 15219186
[No Abstract] [Full Text] [Related]
16. Can we optimise treatment of thrombosis?
Levine MN
Cancer Treat Rev; 2003 Jun; 29 Suppl 2():19-22. PubMed ID: 12887946
[TBL] [Abstract][Full Text] [Related]
17. [Evidence for thrombosis prophylaxis to high-risk patients].
Själander A; Jansson JH; Bergqvist D; Eriksson H; Svensson P
Lakartidningen; 2007 May 14-29; 104(20-21):1585-7. PubMed ID: 17564265
[No Abstract] [Full Text] [Related]
18. Thromboprophylaxis in knee arthroscopy patients: revisiting values and preferences.
Hull RD
Ann Intern Med; 2008 Jul; 149(2):137-9. PubMed ID: 18626053
[No Abstract] [Full Text] [Related]
19. Venous thromboembolic disease in cancer. Optimisation of the use of antithrombotic agents.
Camps C; Juárez A; Iranzo V; Garde J; Blasco A; Sirera R
Clin Transl Oncol; 2007 Mar; 9(3):161-71. PubMed ID: 17403627
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
Burris HA
Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
